Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103415074 | 10341507 | 4 | F | 20140128 | 20160907 | 20140725 | 20160912 | EXP | DE-BRISTOL-MYERS SQUIBB COMPANY-21220868 | BRISTOL MYERS SQUIBB | 73.00 | YR | F | Y | 0.00000 | 20160912 | CN | DE | DE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103415074 | 10341507 | 1 | PS | ABATACEPT | ABATACEPT | 1 | Intravenous (not otherwise specified) | 750 MG, Q4WK | Y | 125118 | 750 | MG | |||||||
| 103415074 | 10341507 | 2 | SS | ABATACEPT | ABATACEPT | 1 | Subcutaneous | 125 MG, QWK | Y | 125118 | 125 | MG | SOLUTION FOR INJECTION | /wk | |||||
| 103415074 | 10341507 | 3 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 20 MG, QWK | U | 0 | 20 | MG | /wk | ||||||
| 103415074 | 10341507 | 4 | C | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | U | 0 | ||||||||||
| 103415074 | 10341507 | 5 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | U | 0 | ||||||||||
| 103415074 | 10341507 | 6 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 103415074 | 10341507 | 7 | C | ETORICOXIB | ETORICOXIB | 1 | Unknown | U | 0 | ||||||||||
| 103415074 | 10341507 | 8 | C | METOPROLOL. | METOPROLOL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 103415074 | 10341507 | 1 | Rheumatoid arthritis |
| 103415074 | 10341507 | 2 | Rheumatoid arthritis |
| 103415074 | 10341507 | 3 | Product used for unknown indication |
| 103415074 | 10341507 | 4 | Product used for unknown indication |
| 103415074 | 10341507 | 5 | Product used for unknown indication |
| 103415074 | 10341507 | 6 | Product used for unknown indication |
| 103415074 | 10341507 | 7 | Product used for unknown indication |
| 103415074 | 10341507 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 103415074 | 10341507 | OT |
| 103415074 | 10341507 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 103415074 | 10341507 | Arthralgia | |
| 103415074 | 10341507 | Hernia obstructive | |
| 103415074 | 10341507 | Hypokalaemia | |
| 103415074 | 10341507 | Ileus | |
| 103415074 | 10341507 | Ovarian adenoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 103415074 | 10341507 | 1 | 201104 | 201509 | 0 | |
| 103415074 | 10341507 | 2 | 20151013 | 0 |